1. Multi‐omics molecular phenotyping reveals the potential mechanisms of chemotherapy response and resistance in small cell lung cancer.
- Author
-
Cheng, Ying, Hu, Jie, Gao, Xuan, Yan, Bingfa, Xu, Zelong, Liu, Ying, Zhu, Jing, Liu, Zhentian, Wang, Ying, Wang, Junfeng, Xin, Ying, Zheng, Ke, Yang, Yawen, Xia, Xuefeng, Yi, Xin, Niu, Kai, Yang, Changliang, Cui, Hongxia, Wang, Yanrong, and Yang, Guang
- Subjects
SMALL cell lung cancer ,VASCULAR endothelial growth factor receptors ,MOLECULAR biology ,MULTIOMICS - Abstract
This article discusses a study conducted on Chinese patients with small cell lung cancer (SCLC) to understand the mechanisms of chemotherapy response and resistance. The study analyzed the multi-omics characteristics of tumor tissue, circulating tumor cells (CTCs), and circulating tumor DNA (ctDNA) in SCLC patients. The results showed that patients who responded well to chemotherapy had better survival outcomes. The study also identified potential molecular mechanisms, such as KDR mutation, PI3K amplification, and activation of VEGF and KRAS pathways, that contribute to chemotherapy resistance. The findings suggest that targeted therapies and immunotherapy may benefit patients who are resistant to chemotherapy. Further research is needed to determine the most appropriate treatments for recurring patients. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF